- Atezolizumab2018 | Faculty of Physical Education and Sport, First Faculty of Medicine
- Atezolizumab in the treatment of lung cancer +12021 | Publication without faculty affiliation
- Atezolizumab and bevacizumab in the treatment of hepatocellular carcinoma2020 | Faculty of Medicine in Pilsen
- Atezolizumab in the first line of treatment for non-squamous metastatic non-small cell lung cancer2019 | Second Faculty of Medicine
- Advanced hepatocellular carcinoma and successfully targeted the first-line treatment with atezolizumab and bevacizumab according to IMbrave150 trial2021 | Faculty of Medicine in Pilsen
- Atezolizumab in the first-line treatment of non-small cell lung cancer - the IMpower110 trial2022 | First Faculty of Medicine
- Atezolizumab v léčbě uroteliálního karcinomu2021 | First Faculty of Medicine
- Atezolizumab in the treatment of non-small cell lung cancer patients with EGFR and ALK mutation or rearrangement2019 | First Faculty of Medicine
- Atezolizumab v léčbě nemalobuněčného karcinomu plic u předléčených pacientů2020 | Third Faculty of Medicine
- Immunotherapy of small cell lung cancer2020 | Publication without faculty affiliation
- Immunooncologic therapy of lung cancer. Present and perspectives2020 | Faculty of Medicine in Pilsen
- Small cell lung cancer, current treatment and perspectives2023 | Faculty of Medicine in Pilsen
- Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial2023 | First Faculty of Medicine
- Atezolizumab ve studii OAK naděje pro nemocné s pokročilým nemalobuněčným karcinomem plic2020 | Third Faculty of Medicine
- Durvalumab in the treatment of small cell lung cancer2020 | Faculty of Medicine in Pilsen
- Current treatment options for squamous cell carcinoma of the lung2018 | Faculty of Medicine in Pilsen
- Immunotherapy for lung cancer at the ESMO virtual congress2020 | Publication without faculty affiliation
- Real-accesible novelties in immunotherapy from the perspective of a medical oncologist working in the Czech Republic2020 | Faculty of Medicine in Hradec Králové
- Atezolizumab ve druhé linii léčby nemalobuněčného plicního karcinomu2020 | First Faculty of Medicine
- How to manage side effects of immunotherapy How to manage side effects of immunotherapy2020 | Faculty of Medicine in Hradec Králové
- Immunotherapy of lung cancer and basic principle of immune system acting2021 | Faculty of Medicine in Pilsen
- Virtual WCLC 2020 and Immunotherapy - Conference Report2021 | Publication without faculty affiliation
- Current systemic treatment of bladder cancer2021 | First Faculty of Medicine
- Antiangiogenic therapy of lung cancer2018 | Second Faculty of Medicine
- Immunotherapy in the first line treatment of non-small cell lung cancer2021 | Publication without faculty affiliation
- ASCO 2020 virtual conference and treatment of lung cancer2020 | Publication without faculty affiliation
- Immunotherapy of triple negative breast cancer2019 | Faculty of Physical Education and Sport, First Faculty of Medicine, Central Library of Charles University
- Chemoimmunotherapy in the treatment of ES-SCLC2021 | First Faculty of Medicine
- Studie IMpower110 a její výsledky2021 | First Faculty of Medicine